Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Archives of Gynecology and Obstetrics
Erschienen in: Archives of Gynecology and Obstetrics 5/2010

01.05.2010 | Original Article

Altered gene profile of placenta from women with intrahepatic cholestasis of pregnancy

verfasst von: Jing Wei, Huimin Wang, Xiaofu Yang, Minyue Dong, Zhengping Wang

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate the alterations in gene profile of placenta from pregnant women with intrahepatic cholestasis of pregnancy (ICP) and to enhance the insight of etiology and pathogenesis of ICP.

Methods

Ten pregnant women diagnosed ICP were recruited and 10 healthy pregnant women served as control. Four samples were taken from each placenta and RNA was isolated. Gene expression was analyzed with microarray and real time PCR was used to validate the differentially expressed genes.

Results

392 genes were found differentially expressed. Among these differentially expressed genes, 280 were up-regulated and 112 were down-regulated. These differentially expressed genes involved 20 categories including genes involved in transportation, cell growth, apoptosis and immune response that were putatively participated the pathogenesis of ICP.

Conclusions

293 differentially expressed genes of 20 categories were found in ICP placenta, suggesting the diversity of gene expression alteration and the complexity of etiology and pathogenesis of ICP.
Literatur
1.
Lammert F, Marschall HU, Glantz A, Matern S (2000) Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 33(6):1012–1021CrossRefPubMed
2.
Beuers U, Pusl T (2006) Intrahepatic cholestasis of pregnancy—a heterogeneous group of pregnancy-related disorders? Hepatology 43(4):647–649CrossRefPubMed
3.
4.
Fisk NM, Storey GN (1988) Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 95(11):1137–1143PubMed
5.
Bacq Y, Sapey T, Bréchot MC, Pierre F, Fignon A, Dubois F (1997) Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 26(2):358–364CrossRefPubMed
6.
Rioseco AJ, Ivankovic MB, Manzur A et al (1994) Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 170(3):890–895PubMed
7.
Laatikainen T, Ikonen E (1975) Fetal prognosis in obstetric hepatosis. Ann Chir Gynaecol Fenn 64(3):155–164PubMed
8.
Shaw D, Frohlich J, Wittmann BA, Willms M (1982) A prospective study of 18 patients with cholestasis of pregnancy. Am J Obstet Gynecol 142(6 Pt 1):621–625PubMed
9.
Alsulyman OM, Ouzounian JG, Ames-Castro M, Goodwin TM (1996) Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol 175(4 Pt 1):957–960CrossRefPubMed
10.
Williamson C, Hems LM, Goulis DG et al (2004) Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. BJOG 111(7):676–681CrossRefPubMed
11.
Zhao YJ, Yue YF, Liu XQ, Li SH, Liu ZY, Wang Y (2004) Study on relationship between serum cholylglycine and placental apoptosis in patients with intrahepatic cholestasis of pregnancy (in Chinese). Zhonghua Fu Chan Ke Za Zhi 39(7):446–448PubMed
12.
Wang DM, La XL, Ding L (2003) Study on apoptosis and expression of Fas, FasL in placenta of intrahepatic cholestasis of pregnancy (in Chinese). Chin J Perinat Med 6(4):199–201
13.
Zhang SJ (2007) Immunohistochemical study on the expression of TNF-α in placenta in intrahepatic cholestasis of pregnancy (in Chinese). Acta Acad Med Xuzhou 27(7):451–452
14.
Dong MY, He J, Wang ZP (2003) Placental expression of epidermal growth factor receptor in intrahepatic cholestasis of pregnancy. Chin J Obstet Gynecol 38(2):106–107
15.
Watson A, Mazumder A, Stewart M, Balasubramanian S (1998) Technology for microarray analysis of gene expression. Curr Opin Biotechnol 9:609–614CrossRefPubMed
16.
17.
Schena M, Shalon D, Davis RW, Brown PO (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270(20):467–470CrossRefPubMed
18.
Dong M, Shi Y (1996) Evaluation of cholic glycine in serum and hemorrheological parameters in women with intrahepatic cholestasis of pregnancy (in Chinese). Curr Adv Obstet Gynecol 5:251–253
19.
Dong M, Wang Z, He J, Shi Y, Yang P, Pan Y (1999) Increased anticardiolipin antibody in intrahepatic cholestasis of pregnancy (in Chinese). Chin J Obstet Gynecol 34:491
20.
Dong M, Xie X, Wang Z, He J, Zhou J (2002) Impaired mixed lymphocyte reaction in intrahepatic cholestasis of pregnancy (in Chinese). Gynecol Obstet Invest 54:191–195CrossRefPubMed
21.
22.
Wang ZP, Dong MY, Chu HN, He J (2004) Increased serum levels of neopterin and soluble interleukin-2 receptor in intrahepatic cholestasis of pregnancy. Acta Obstet Gynecol Scand 83(11):1067–1070PubMed
23.
Peng B, Liu SY (2002) Study of relationship between T helper cell type1 and type2 cytokines and intrahepatic cholestasis of pregnancy (in Chinese). Zhonghua Fu Chan Ke Za Zhi 37(9):516–518PubMed
24.
Ling B, Yao FQ, Zhou Y, Chen ZZ, Shen GD, Zhu YY (2007) Cell-mediated immunity imbalance in patients with intrahepatic cholestasis of pregnancy. Cell Mol Immunol 4(1):71–75PubMed
25.
Koehler LH, Benz EJ (1962) Serum adenosine deaminase: methodology and clinical applications. Clin Chem 8:133–140PubMed
26.
Ungerer JP, Oosthuizen HM, Bissbort SH, Vermaak WJ (1992) Serum adenosine deaminase: isoenzymes and diagnostic application. Clin Chem 38(7):1322–1326PubMed
27.
Trajkovic V, Sweet MJ, Xu D (2004) T1/ST2—an IL-1 receptor-like modulator of immune responses. Cytokine Growth Factor Rev 15(2–3):87–95CrossRefPubMed
28.
Xu D, Chan WL, Leung BP et al (1998) Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 187(5):787–794CrossRefPubMed
29.
Löhning M, Stroehmann A, Coyle AJ et al (1998) T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA 95(12):6930–6935CrossRefPubMed
30.
Coyle AJ, Lloyd C, Tian J et al (1999) Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med 190(7):895–902CrossRefPubMed
31.
Dann AT, Kenyon AP, Wierzbicki AS, Seed PT, Shennan AH, Tribe RM (2006) Plasma lipid profiles of women with intrahepatic cholestasis of pregnancy. Obstet Gynecol 107(1):106–114PubMed
32.
Spreyer P, Schaal H, Kuhn G et al (1990) Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibroblasts of peripheral nerve. EMBO J 9(8):2479–2484PubMed
33.
Xia SY, Chen ZQ, Li L (2003) Change of vascular endothelial growth factor (VEGF) and its significance in placenta for patients with intrahepatic cholestasis in pregnancy (in Chinese). J Chin Phys 5(8):1068–1070
34.
Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75(1):59–72PubMed
35.
DeChiara TM, Efstratiadis A, Robertson EJ (1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345(6270):78–80CrossRefPubMed
36.
Lin CG, Leu SJ, Chen N et al (2003) CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem 278(26):24200–24208CrossRefPubMed
37.
Ellis PD, Chen Q, Barker PJ, Metcalfe JC, Kemp PR (2000) Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury. Arterioscler Thromb Vasc Biol 20(8):1912–1919PubMed
38.
Gellhaus A, Schmidt M, Dunk C, Lye SJ, Kimmig R, Winterhager E (2006) Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia. Mol Hum Reprod 12(6):389–399CrossRefPubMed
39.
Chen M, Sun LZ, Ding HJ, Wu WP (2007) The relationship between intrahepatic cholestasis and placenta cells apoptosis in pregnancy (in Chinese). Mod Med J 35(6):428–431
40.
Perez MJ, Macias RI, Marin JJ (2006) Maternal cholestasis induces placental oxidative stress and apoptosis. Protective effect of ursodeoxycholic acid. Placenta 27(1):34–41CrossRefPubMed
41.
Huang JR, Liu J, Chang SF (2006) Mechanism of farnesoid X receptor and bile salt excretory pump on bile acid transport in placenta of intrahepatic cholestasis of pregnany (in Chinese). Chongqing Med J 174:9–1950
42.
Floreani A, Carderi I, Paternoster D et al (2008) Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy. Dig Liver Dis 40(5):366–370CrossRefPubMed
43.
Arrese M, Macias RI, Briz O, Perez MJ, Marin JJ (2008) Molecular pathogenesis of intrahepatic cholestasis of pregnancy. Expert Rev Mol Med 28:10:e9
44.
Serrano MA, Macias RIR, Briz O et al (2007) Expression in human trophoblast and choriocarcinoma cell lines, BeWo, Jeg-3 and JAr of genes involved in the hepatobiliary-like excretory function of the placenta. Placenta 28:107–117CrossRefPubMed
45.
Patel P, Weerasekera N, Hitchins M, Boyd CAR, Johnston DG, Williamson C (2003) Semi quantitative expression analysis of MDR3, FIC1, BSEP, OATP-A, OATP-C, OATP-D, OATP-E and NTCP gene transcripts in 1st and 3rd trimester human placenta. Placenta 24:39–44CrossRefPubMed
Metadaten
Titel
Altered gene profile of placenta from women with intrahepatic cholestasis of pregnancy
verfasst von
Jing Wei
Huimin Wang
Xiaofu Yang
Minyue Dong
Zhengping Wang
Publikationsdatum
01.05.2010
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 5/2010
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-009-1156-3

Weitere Artikel der Ausgabe 5/2010

Archives of Gynecology and Obstetrics 5/2010 Zur Ausgabe

General Gynecology

Hemoglobin levels predict quality of life in women with heavy menstrual bleeding

Materno-fetal Medicine

3D color Doppler of monoamniotic twin cord entanglement

General Gynecology

Evaluation of outcomes after transabdominal cervicoisthmic cerclage

Materno-fetal Medicine

Human immunodeficiency virus and pregnancy

Materno-fetal Medicine

Bilateral humerus fracture in a neonate after cesarean delivery

Materno-fetal Medicine

Carrier-mediated uptake of Levofloxacin by BeWo cells, a human trophoblast cell line

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise